Child/Adolescent Schedule

The recommended healthcare preventive needs are constantly changing.  For example, an annual physical/medical examination is not always recommended or necessary.  Although your personal health could impact these recommendations, the schedules below can help recommend the services that should be considered based upon your age.

Printable PDF

Each year Influenza Vaccination only
Newborn HepB At the hospital
3-5 days Encounter
2 weeks - 1 month    Encounter Optional
2 months HepB, PCV13, RV5, DTaP-IPV/Hib Encounter
4 months PCV13, RV5, DTaP-IPV/Hib Encounter
6 months HepB, PCV13, RV5, DTaP-IPV/Hib Encounter/Alternative Option
9 months Encounter
12 months HepA, MMR, VAR Encounter/Alternative Option
15 months PCV13, DTaP-IPV/Hib Encounter
18 months Encounter/Alternative Option
2 years HepA Encounter
3 years Encounter
4 years 4-6 years - DTaP, MMRV, IPV Encounter/Alternative Option
5 years Encounter
6-7 years Encounter
8-9 years 9 years - HPV (2 doses 6 months apart) Encounter
10-11 years 11 years - MCV4, Tdap Encounter
12-13 years Encounter
14-15 years Encounter
16-17 years 16 years - MCV4, MenB* (Bexsero - 2 doses one month apart) Encounter
18-19 years Encounter
20-21 years   Encounter


DTaP: Diphtheria-Tetanus-acellular Pertussis vaccine (pediatric form)
DTaP-IPV/Hib: Diphtheria-Tetanus-acellular Pertussis vaccine-Inactivated Polio Vaccine/Haemophilus influenzae type b vaccine
HepA: Hepatitis A vaccine (minimum spacing 6 months between doses)
HepB: Hepatitis B vaccine
HPV: Human Papillomavirus Vaccine (2 doses 6 months apart for immunocompetent patients who get the 1st dose before 15 years of age; otherwise 3 doses at 0, 2 and 6 months)
IPV: Inactivated Polio Vaccine
MCV4: Meningococcal Conjugate Vaccine (quadrivalent)
*MenB: Meningococcal B vaccine (optional for 16 to 23 years of age; Bexsero - 2 doses at least 1 month apart)
MMR: Measles-Mumps-Rubella vaccine
MMRV: Measles-Mumps-Rubella-Varicella vaccine (give MMR and VAR instead if before age 4 or after age 12 years)
PCV13: Pneumococcal Conjugate Vaccine (13-valent)
RV5: Rotavirus (pentavalent) vaccine (First dose no later than 14 weeks, 6 days of age and last dose no later than 8 months, 0 days of age).
Tdap: Tetanus-diphtheria-acellular pertussis vaccine (adolescent-adult form)
VAR: Varicella zoster vaccine (chicken pox)


Encounter: Well child visit face to face with a health care provider and care team. 
Encounter Optional: Provider, care team member and parent decide together at time of 3-5 days well visit whether the newborn needs a visit at 2 or 4 weeks of age. 
Alternative Option: Health promotion visit can be a face-to-face encounter with a health care team member (e.g. Nurse well visit), or an alternative non-face-to-face visit as recommended by the health care team (e.g., developmental screening only at 18 months).